DE eng

Search in the Catalogues and Directories

Page: 1 2 3
Hits 1 – 20 of 46

1
The trans-ancestral genomic architecture of glycemic traits
Chen, J; Spracklen, CN; Marenne, G. - : Nature Research, 2021
BASE
Show details
2
The trans-ancestral genomic architecture of glycemic traits.
BASE
Show details
3
The trans-ancestral genomic architecture of glycemic traits.
In: Nature genetics, vol. 53, no. 6, pp. 840-860 (2021)
BASE
Show details
4
Study of central exclusive [Image: see text] production in proton-proton collisions at [Formula: see text] and 13TeV
In: Eur Phys J C Part Fields (2020)
BASE
Show details
5
Understanding (Mis)Behavior on the EOSIO Blockchain
Huang, Y; Wang, H; Wu, L. - 2020
BASE
Show details
6
Towards emotion recognition for virtual environments: an evaluation of eeg features on benchmark dataset [<Journal>]
Menezes, M. L. R. [Verfasser]; Samara, A. [Sonstige]; Galway, L. [Sonstige].
DNB Subject Category Language
Show details
7
Counting on number: effects of number information on grammatical processing of mass and count nouns
Wang, H.; Fieder, N.; Nickels, L.. - : Routledge, 2017
BASE
Show details
8
Children reading spoken words: Interactions between vocabulary and orthographic expectancy
BASE
Show details
9
Search for dark matter produced in association with heavy-flavor quark pairs in proton-proton collisions at [Formula: see text]
Sirunyan, A. M.; Tumasyan, A.; Adam, W.. - : Springer Berlin Heidelberg, 2017
BASE
Show details
10
Multilingual representations for low resource speech recognition and keyword search
BASE
Show details
11
Improving object and event monitoring on twitter through lexical analysis and user profiling
Zhang, Y.; Szabo, C.; Sheng, Q.. - : Springer, 2016
BASE
Show details
12
Multilingual representations for low resource speech recognition and keyword search ...
Cui, J; Kingsbury, B; Ramabhadran, B. - : Apollo - University of Cambridge Repository, 2015
BASE
Show details
13
Multilingual representations for low resource speech recognition and keyword search
Cui, J; Kingsbury, B; Ramabhadran, B. - : IEEE, 2015. : 2015 IEEE Workshop on Automatic Speech Recognition and Understanding, ASRU 2015 - Proceedings, 2015
BASE
Show details
14
Measurement of the muon reconstruction performance of the ATLAS detector using 2011 and 2012 LHC proton-proton collision data.
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2014)
BASE
Show details
15
Predictors of Orthographic Learning of Regular and Irregular Words
In: Symplectic Elements at Oxford ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2013)
BASE
Show details
16
Basal insulin and cardiovascular and other outcomes in dysglycemia.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
Abstract: BACKGROUND: The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested. METHODS: We randomly assigned 12,537 people (mean age, 63.5 years) with cardiovascular risk factors plus impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes to receive insulin glargine (with a target fasting blood glucose level of ≤95 mg per deciliter [5.3 mmol per liter]) or standard care and to receive n-3 fatty acids or placebo with the use of a 2-by-2 factorial design. The results of the comparison between insulin glargine and standard care are reported here. The coprimary outcomes were nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes and these events plus revascularization or hospitalization for heart failure. Microvascular outcomes, incident diabetes, hypoglycemia, weight, and cancers were also compared between groups. RESULTS: The median follow-up was 6.2 years (interquartile range, 5.8 to 6.7). Rates of incident cardiovascular outcomes were similar in the insulin-glargine and standard-care groups: 2.94 and 2.85 per 100 person-years, respectively, for the first coprimary outcome (hazard ratio, 1.02; 95% confidence interval [CI], 0.94 to 1.11; P=0.63) and 5.52 and 5.28 per 100 person-years, respectively, for the second coprimary outcome (hazard ratio, 1.04; 95% CI, 0.97 to 1.11; P=0.27). New diabetes was diagnosed approximately 3 months after therapy was stopped among 30% versus 35% of 1456 participants without baseline diabetes (odds ratio, 0.80; 95% CI, 0.64 to 1.00; P=0.05). Rates of severe hypoglycemia were 1.00 versus 0.31 per 100 person-years. Median weight increased by 1.6 kg in the insulin-glargine group and fell by 0.5 kg in the standard-care group. There was no significant difference in cancers (hazard ratio, 1.00; 95% CI, 0.88 to 1.13; P=0.97). CONCLUSIONS: When used to target normal fasting plasma glucose levels for more than 6 years, insulin glargine had a neutral effect on cardiovascular outcomes and cancers. Although it reduced new-onset diabetes, insulin glargine also increased hypoglycemia and modestly increased weight. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.).
Keyword: Aged; Blood Glucose/analysis; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/etiology; Cholesterol/blood; Combination; Diabetes Mellitus; Double-Blind Method; Drug Therapy; Fasting; Fatty Acids; Female; Follow-Up Studies; Glucose Intolerance/complications; Glucose Intolerance/drug therapy; Hospitalization; Humans; Hypoglycemia/chemically induced; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/therapeutic use; Incidence; Insulin; Intention to Treat Analysis; Long-Acting/adverse effects; Long-Acting/therapeutic use; Male; Middle Aged; Omega-3/therapeutic use; Proportional Hazards Models; Triglycerides/blood; Type 2/complications; Type 2/drug therapy
URL: https://doi.org/10.1056/NEJMoa1203858
https://serval.unil.ch/notice/serval:BIB_24F963809D9F
BASE
Hide details
17
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
BASE
Show details
18
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
In: New England Journal of Medicine, vol. 367, no. 23, pp. 2204-2213 (2012)
BASE
Show details
19
Article 6 (27 pages) A Linguistically Inspired Statistical Model for Chinese Punctuation Generation
In: Association for Computing Machinery. ACM transactions on Asian language information processing. - New York, NY : ACM 9 (2010) 2
OLC Linguistik
Show details
20
Computing with words in risk assessment
Liu, J; Martínez, L; Wang, H. - : Taylor & Francis, 2010
BASE
Show details

Page: 1 2 3

Catalogues
0
0
20
0
1
0
0
Bibliographies
3
0
0
0
0
0
0
0
1
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
21
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern